Singapore legislation
Regulation 4
of Healthcare Services (Collaborative Prescribing Service) Regulations 2023
Regulation 4
Medical practitioner‑in‑charge (CP)
Subregulation 1
For the purposes of regulation 3(1)(c), the medical practitioner‑in‑charge (CP) must be an individual who —
is a medical practitioner and a personnel of the licensee;
is the medical director, or a member of the medical board or clinical board, of the licensee; and
has not, in the period of 3 years before the medical practitioner’s employment or engagement by the licensee, been the subject of any order made by a Disciplinary Tribunal under section 59D(2) or 59E of the Medical Registration Act 1997.
Subregulation 2
The functions of the medical practitioner‑in‑charge (CP) are as follows:
to oversee the provision of the collaborative prescribing service by the licensee to ensure that it is provided in a proper, effective and safe manner;
to consider the findings of the service review committee mentioned in regulation 8(b) and (g) in respect of the provision of any collaborative prescribing service by the licensee and ensure that necessary measures are implemented to address any issue raised by the service review committee;
where the medical practitioner‑in‑charge (CP) is satisfied that a collaborative prescribing service by any collaborative prescribing practitioner has not been provided in a proper, effective and safe manner, to make a recommendation for the cessation of the collaborative prescribing service by that collaborative prescribing practitioner and provide the licensee with his or her reasons for the recommendation.
Subregulation 3
In this regulation, “Disciplinary Tribunal” has the meaning given by section 2(1) of the Medical Registration Act 1997.